🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
PVL
$PVLA
🔒 US EquitiesPalvella Therapeutics Inc
AVG HISTORICAL GAP
-1.38%
MAX GAP RECORD
-5.21%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $PVLA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$PVLA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 05, 2026 Earnings Release 2026-11-05 (UNDETERMINED) | 🔮 UPCOMING 🔒 |
| Aug 04, 2026 Earnings Release 2026-08-04 (UNDETERMINED) |
+0.00%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
+0.31%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (AFTER CLOSE) |
-5.21%
|
| Aug 14, 2025 Earnings Release 2025-08-14 (AFTER CLOSE) |
+2.21%
|
| May 15, 2025 Earnings Release 2025-05-15 (BEFORE OPEN) |
-2.81%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.6%
Bullish Gaps (1)
Bearish Gaps (2)
Neutral / Flat (1)
📖 Intelligence Summary
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗